219 related articles for article (PubMed ID: 8754409)
1. [Evaluation of factors influencing platelet aggregation in patients with chronic glomerulonephritis (CGN)].
Zdrojewski Z; Raszeja-Specht A; Kustosz J; Skibowska A; Rutkowski B
Przegl Lek; 1996; 53(5):434-8. PubMed ID: 8754409
[TBL] [Abstract][Full Text] [Related]
2. [Hypercoagulation in patients with nephrotic syndrome].
Zdrojewski Z; Raszeja-Specht A; Skibowska A; Owczarzak A; Rutkowski B
Pol Merkur Lekarski; 1997 Jan; 2(9):201-4. PubMed ID: 10907029
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of platelet membrane structure in patients with chronic glomerulonephritis (CGN)].
Zdrojewski Z; Nowak J; Raszeja-Specht A; Skibowska A; Kustosz J; Rutkowski B
Przegl Lek; 1996; 53(5):431-3. PubMed ID: 8754408
[TBL] [Abstract][Full Text] [Related]
4. Influence of spontaneous platelet aggregation on progression of glomerular disease.
Zdrojewski Z; Lizakowski S; Raszeja-Specht A; Skibowska A; Rutkowski B
Nephron; 2002 Sep; 92(1):36-42. PubMed ID: 12187082
[TBL] [Abstract][Full Text] [Related]
5. Activation of platelets in patients with chronic proliferative glomerulonephritis and the nephrotic syndrome.
Tomura S; Ida T; Kuriyama R; Chida Y; Takeuchi J; Motomiya T; Yamazaki H
Clin Nephrol; 1982 Jan; 17(1):24-30. PubMed ID: 6459902
[TBL] [Abstract][Full Text] [Related]
6. [Platelet dysfunction and pregnancy in gestational exacerbation of chronic glomerulonephritis].
Kozlovskaia NL; Tareeva IE; Krylova MIu; Artem'eva VB
Ter Arkh; 1999; 71(6):43-5. PubMed ID: 10420455
[TBL] [Abstract][Full Text] [Related]
7. [Platelet aggregation and the fibronectin level of the blood in children with chronic glomerulonephritis].
Pinelis VG; Razdol'kina TI; Sergeeva TV; Gozalishvili TV; Storozhevykh TP; Tsygin AN
Urol Nefrol (Mosk); 1995; (4):17-9. PubMed ID: 7571193
[TBL] [Abstract][Full Text] [Related]
8. [Endothelium and platelets in pregnant women with chronic glomerulonephritis and therapeutic efficacy of acetylsalicylic acid and dipiridamol].
Rogov VA; Shilov EM; Kozlovskaia NL; Gordovskaia NB; Sidorova IS; Krylova MIu; Artem'eva VB
Ter Arkh; 2004; 76(12):58-64. PubMed ID: 15724929
[TBL] [Abstract][Full Text] [Related]
9. [Lipiduria in the nephrotic syndrome].
Neverov NI; Nikitina EA
Ter Arkh; 1992; 64(6):16-8. PubMed ID: 1440328
[TBL] [Abstract][Full Text] [Related]
10. [Clinical implication of urine test for markers of endothelial dysfunction and angiogenesis factors in assessment of tubulointerstitial fibrosis in chronic glomerulonephritis].
Bobkova IN; Kozlovskaia LV; Rameeva AS; Varshavskiĭ VA; Golitsyna EP
Ter Arkh; 2007; 79(6):10-5. PubMed ID: 17684960
[TBL] [Abstract][Full Text] [Related]
11. [The assessment of platelet function in patients with essential thrombocythemia].
Treliński J; Tybura M; Chojnowski K
Pol Merkur Lekarski; 2008 Jul; 25(145):19-22. PubMed ID: 18839608
[TBL] [Abstract][Full Text] [Related]
12. [Platelet defects in chronic myeloproliferative disorders].
Raszeja-Specht A; Skibowska A; Kabata J; Hellmann A
Acta Haematol Pol; 1994; 25(3):253-60. PubMed ID: 7992598
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive study on platelet function, hemostasis, fibrinolysis, peripheral serotonergic system and serum lipids in nephrotic syndrome.
Małyszko J; Małyszko JS; Pawlak D; Pawlak K; Rydzewski A; Myśliwiec M; Buczko W
Pol J Pharmacol; 1996; 48(2):191-5. PubMed ID: 9112650
[TBL] [Abstract][Full Text] [Related]
14. Plasma tissue factor and tissue factor pathway inhibitor in patients with primary glomerulonephritis.
Lizakowski S; Zdrojewski Z; Jagodzinski P; Rutkowski B
Scand J Urol Nephrol; 2007; 41(3):237-42. PubMed ID: 17469034
[TBL] [Abstract][Full Text] [Related]
15. [The concentration of adenine nucleotides in platelets of patients with primary chronic glomerulonephritis].
Lizakowski S; Zdrojewski Z; Jagodziński P; Słomińska E; Rutkowski B
Pol Arch Med Wewn; 2000 Aug; 104(2):467-73. PubMed ID: 11303312
[TBL] [Abstract][Full Text] [Related]
16. Effect of hypoalbuminemia on the increased serum cholesteryl ester transfer protein concentration in children with idiopathic nephrotic syndrome.
Zhang C; Yao M; Wang X; Zhuang Y; Xia Z; Yang Y; Li Y; Liu X; Li K; Wang J
Clin Biochem; 2007 Aug; 40(12):869-75. PubMed ID: 17555738
[TBL] [Abstract][Full Text] [Related]
17. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
18. [Cyclophosphamide efficacy in maintenance therapy of nephrotic syndrome in patients with chronic glomerulonephritis].
Ter Arkh; 2004; 76(9):26-8. PubMed ID: 15532372
[TBL] [Abstract][Full Text] [Related]
19. Preliminary study showing the relationship between platelet fibronectin, sialic acid, and ADP-induced aggregation levels in coronary heart disease.
Bütün II; Ekmekçi H; Sönmez H; Gürel C; Ciftçi O; Ulutin T; Kökoğlu E; Domaniç N; Dirican A
Clin Appl Thromb Hemost; 2007 Jul; 13(3):308-12. PubMed ID: 17636193
[TBL] [Abstract][Full Text] [Related]
20. [Selected parameters of blood platelet function in patients with myeloproliferative syndrome].
Zuk E
Ann Acad Med Stetin; 1998; 44():137-54. PubMed ID: 9857536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
